Company
Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
79 stories · page 1 of 4
Archive
US stocks close sharply higher as Biden and Trump await their fates
As of market close, Biden is seeing his lead widen in Nevada while Trump’s shrinks in Georgia and Pennsylvania
Investments and investor services
LATE MOVERS: Tesla shares slip after news of $35,000 Model 3’s launch
Also on the move are Booking Holdings, Box Inc, Bristol-Myers Squibb, Celgene, Gap, HP and Nordstrom
MORNING MOVERS: Celgene crashes as Bristol-Myers takeover thrown into doubt
Also in play in are Square Inc, Box Inc and HP Inc
Archive
EARLY MOVERS: Celgene crashes in pre-market as Bristol-Myers takeover thrown into doubt
Also in play in pre-market deals New York is Square Inc and Box Inc
Archive
EARLY MOVERS: Celgene crashes in pre-market as Bristol-Myers takeover thrown into doubt
Also in play in pre-market deals New York is Square Inc and Box Inc
Eli Lilly’s $8B bet on Loxo is a ‘vote of confidence’ for novel scientific approaches that use DNA to treat cancer
Genprex Inc CEO Rodney Varner said the deal was ‘further validation’ of the promise of cancer therapies that target specific cancer-causing genetic abnormalities